Purdue Pharma welcomes new OTC business lead

Carrie Chomiak will work with the company's OTC assets, development, implementation, communication and more.
Carrie Chomiak will work with the company's OTC assets, development, implementation, communication and more. | File photo

Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener.

Chomiak previously worked with Pfizer Consumer Healthcare, where she was part of the U.S. executive leadership team. She also played an integral role in the U.S. digestive health franchise, and has had experience working with brands such a Centrum, Caltrate, Advil, Emergen-C, Robitussin, Dimetapp and Chapstick.

"Carrie brings very strong sales and marketing leadership skills and experience in consumer brands to optimize our existing over-the-counter products as well as to partner with our business development team to accelerate the expansion of our OTC portfolio," Purdue Pharma President and CEO Mark Timney said.

Chomiak will work with the company's OTC assets, development, implementation, communication and more.

"I look forward to contributing to the organization's ongoing evolution and creating value both organically and through strategic business development initiatives," Chomiak said.